NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

表紙
市場調查報告書

全球前列腺切片檢查市場(2020年∼2024年)

Global Prostate Biopsy Market 2020-2024

出版商 TechNavio (Infiniti Research Ltd.) 商品編碼 974073
出版日期 內容資訊 英文 120 Pages
訂單完成後即時交付
價格
全球前列腺切片檢查市場(2020年∼2024年) Global Prostate Biopsy Market 2020-2024
出版日期: 2020年11月23日內容資訊: 英文 120 Pages
簡介

全球前列腺切片檢查的市場規模在2020年∼2024年間,預測將成長到3億8,023萬美元,預計在預測期間內將以11%的年複合成長率推移。市場成長的主要因素有前列腺癌的發生率增加和診斷中心數的增加。

本報告提供前列腺切片檢查市場調查,提供市場概要,市場成長要素及阻礙因素分析,各產品·各終端用戶·各地區的市場規模的變化與預測,供應商分析,市場機會等全面性資訊。

目錄

摘要整理

市場形勢

市場規模

  • 市場定義
  • 市場區隔分析
  • 市場規模2019
  • 市場預測:從2019年∼2024年的預測

波特的五力分析

各產品的市場區隔

  • 市場區隔
  • 各產品比較
  • 前列腺針切片檢查-市場規模與預測(2019年-2024年)
  • 前列腺液態切片-市場規模與預測(2019年-2024年)
  • 各產品的市場機會

各終端用戶市場區隔

  • 市場區隔
  • 各終端用戶比較
  • 醫院-市場規模與預測(2019年-2024年)
  • ASC-市場規模與預測(2019年-2024年)
  • 診斷中心-市場規模與預測(2019年-2024年)
  • 各終端用戶市場機會

客戶形勢

各地區形勢

  • 各地區市場區隔
  • 各地區比較
  • 北美-市場規模與預測(2019年-2024年)
  • 歐洲-市場規模與預測(2019年-2024年)
  • 亞洲-市場規模與預測(2019年-2024年)
  • 其他地區-市場規模與預測(2019年-2024年)
  • 主要的主要國家
  • 地區的市場機會
  • 市場推動因素
  • 市場課題
  • 市場趨勢

業者情勢

  • 概要
  • 業者情勢
  • 創造性破壞狀況

供應商分析

  • 交易廠商
  • 供應商的市場定位
  • Bio-Techne Corp.
  • Boston Scientific Corp.
  • Cook Group Inc.
  • F. Hoffmann-La Roche Ltd.
  • Guardant Health Inc.
  • PURE Medical Device SA
  • QIAGEN NV
  • SOMATEX Medical Technologies GmbH
  • Thermo Fisher Scientific Inc.

附錄

目錄
Product Code: IRTNTR45756

Technavio has been monitoring the prostate biopsy market and it is poised to grow by $ 380.23 mn during 2020-2024, progressing at a CAGR of 11% during the forecast period. Our reports on the prostate biopsy market provide a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the growing incidences of prostate cancer and the growing number of diagnostic centers. In addition, growing incidences of prostate cancer is anticipated to boost the growth of the market as well.

The prostate biopsy market analysis includes product segment and geographical landscapes.

Technavio's prostate biopsy market is segmented as below:

By Product

  • Prostate needle biopsy
  • Prostate liquid biopsy

By Geographical Landscapes

  • North America
  • Europe
  • Asia
  • ROW

This study identifies the recurrent revenue from repeat biopsy tests as one of the prime reasons driving the prostate biopsy market growth during the next few years.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our prostate biopsy market report covers the following areas:

  • Prostate biopsy market sizing
  • Prostate biopsy market forecast
  • Prostate biopsy market industry analysis

Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading prostate biopsy market vendors that include Becton, Dickinson and Co., Bio-Techne Corp., Boston Scientific Corp., Cook Group Inc., F. Hoffmann-La Roche Ltd., Guardant Health Inc., PURE Medical Device SA, QIAGEN NV, SOMATEX Medical Technologies GmbH, and Thermo Fisher Scientific Inc. Also, the prostate biopsy market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast an accurate market growth.

Table of Contents

Executive Summary

  • Market Overview

Market Landscape

  • Market ecosystem
  • Value chain analysis

Market Sizing

  • Market definition
  • Market segment analysis
  • Market size 2019
  • Market outlook: Forecast for 2019 - 2024

Five Forces Analysis

  • Five forces summary
  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition

Market Segmentation by Product

  • Market segments
  • Comparison by Product
  • Prostate needle biopsy - Market size and forecast 2019-2024
  • Prostate liquid biopsy - Market size and forecast 2019-2024
  • Market opportunity by Product

Market Segmentation by End user

  • Market segments
  • Comparison by End user
  • Hospitals - Market size and forecast 2019-2024
  • ASCs - Market size and forecast 2019-2024
  • Diagnostic centers - Market size and forecast 2019-2024
  • Market opportunity by End user

Customer landscape

Geographic Landscape

  • Geographic segmentation
  • Geographic comparison
  • North America - Market size and forecast 2019-2024
  • Europe - Market size and forecast 2019-2024
  • Asia - Market size and forecast 2019-2024
  • ROW - Market size and forecast 2019-2024
  • Key leading countries
  • Market opportunity by geography
  • Market drivers
  • Market challenges
  • Market trends

Vendor Landscape

  • Overview
  • Vendor landscape
  • Landscape disruption

Vendor Analysis

  • Vendors covered
  • Market positioning of vendors
  • Bio-Techne Corp.
  • Boston Scientific Corp.
  • Cook Group Inc.
  • F. Hoffmann-La Roche Ltd.
  • Guardant Health Inc.
  • PURE Medical Device SA
  • QIAGEN NV
  • SOMATEX Medical Technologies GmbH
  • Thermo Fisher Scientific Inc.

Appendix

  • Scope of the report
  • Currency conversion rates for US$
  • Research methodology
  • List of abbreviations

Exhibit

  • 1: Key Finding 1
  • 2: Key Finding 2
  • 3: Key Finding 3
  • 4: Key Finding 5
  • 5: Key Finding 6
  • 6: Key Finding 7
  • 7: Key Finding 8
  • 8: Key Finding 9
  • 9: Parent market
  • 10: Market characteristics
  • 11: Offerings of vendors included in the market definition
  • 12: Market segments
  • 13: Global - Market size and forecast 2019 - 2024 ($ million)
  • 14: Global market: Year-over-year growth 2019 - 2024 (%)
  • 15: Five forces analysis 2019 & 2024
  • 16: Bargaining power of buyers
  • 17: Bargaining power of suppliers
  • 18: Threat of new entrants
  • 19: Threat of substitutes
  • 20: Threat of rivalry
  • 21: Market condition - Five forces 2019
  • 22: Product - Market share 2019-2024 (%)
  • 23: Comparison by Product
  • 24: Prostate needle biopsy - Market size and forecast 2019-2024 ($ million)
  • 25: Prostate needle biopsy - Year-over-year growth 2019-2024 (%)
  • 26: Prostate liquid biopsy - Market size and forecast 2019-2024 ($ million)
  • 27: Prostate liquid biopsy - Year-over-year growth 2019-2024 (%)
  • 28: Market opportunity by Product
  • 29: End user - Market share 2019-2024 (%)
  • 30: Comparison by End user
  • 31: Hospitals - Market size and forecast 2019-2024 ($ million)
  • 32: Hospitals - Year-over-year growth 2019-2024 (%)
  • 33: ASCs - Market size and forecast 2019-2024 ($ million)
  • 34: ASCs - Year-over-year growth 2019-2024 (%)
  • 35: Diagnostic centers - Market size and forecast 2019-2024 ($ million)
  • 36: Diagnostic centers - Year-over-year growth 2019-2024 (%)
  • 37: Market opportunity by End user
  • 38: Customer landscape
  • 39: Market share by geography 2019-2024 (%)
  • 40: Geographic comparison
  • 41: North America - Market size and forecast 2019-2024 ($ million)
  • 42: North America - Year-over-year growth 2019-2024 (%)
  • 43: Europe - Market size and forecast 2019-2024 ($ million)
  • 44: Europe - Year-over-year growth 2019-2024 (%)
  • 45: Asia - Market size and forecast 2019-2024 ($ million)
  • 46: Asia - Year-over-year growth 2019-2024 (%)
  • 47: ROW - Market size and forecast 2019-2024 ($ million)
  • 48: ROW - Year-over-year growth 2019-2024 (%)
  • 49: Key leading countries
  • 50: Market opportunity by geography ($ million)
  • 51: Impact of drivers and challenges
  • 52: Vendor landscape
  • 53: Landscape disruption
  • 54: Industry risks
  • 55: Vendors covered
  • 56: Market positioning of vendors
  • 57: Becton, Dickinson and Co. - Overview
  • 58: Becton, Dickinson and Co. - Business segments
  • 59: Becton, Dickinson and Co. - Key offerings
  • 60: Becton, Dickinson and Co. - Key customers
  • 61: Becton, Dickinson and Co. - Segment focus
  • 62: Bio-Techne Corp. - Overview
  • 63: Bio-Techne Corp. - Business segments
  • 64: Bio-Techne Corp. - Key offerings
  • 65: Bio-Techne Corp. - Key customers
  • 66: Bio-Techne Corp. - Segment focus
  • 67: Boston Scientific Corp. - Overview
  • 68: Boston Scientific Corp. - Business segments
  • 69: Boston Scientific Corp. - Key offerings
  • 70: Boston Scientific Corp. - Key customers
  • 71: Boston Scientific Corp. - Segment focus
  • 72: Cook Group Inc. - Overview
  • 73: Cook Group Inc. - Product and service
  • 74: Cook Group Inc. - Key offerings
  • 75: Cook Group Inc. - Key customers
  • 76: Cook Group Inc. - Segment focus
  • 77: F. Hoffmann-La Roche Ltd. - Overview
  • 78: F. Hoffmann-La Roche Ltd. - Business segments
  • 79: F. Hoffmann-La Roche Ltd. - Key offerings
  • 80: F. Hoffmann-La Roche Ltd. - Key customers
  • 81: F. Hoffmann-La Roche Ltd. - Segment focus
  • 82: Guardant Health Inc. - Overview
  • 83: Guardant Health Inc. - Business segments
  • 84: Guardant Health Inc. - Key offerings
  • 85: Guardant Health Inc. - Key customers
  • 86: Guardant Health Inc. - Segment focus
  • 87: PURE Medical Device SA - Overview
  • 88: PURE Medical Device SA - Product and service
  • 89: PURE Medical Device SA - Key offerings
  • 90: PURE Medical Device SA - Key customers
  • 91: PURE Medical Device SA - Segment focus
  • 92: QIAGEN NV - Overview
  • 93: QIAGEN NV - Business segments
  • 94: QIAGEN NV - Key offerings
  • 95: QIAGEN NV - Key customers
  • 96: QIAGEN NV - Segment focus
  • 97: SOMATEX Medical Technologies GmbH - Overview
  • 98: SOMATEX Medical Technologies GmbH - Product and service
  • 99: SOMATEX Medical Technologies GmbH - Key offerings
  • 100: SOMATEX Medical Technologies GmbH - Key customers
  • 101: SOMATEX Medical Technologies GmbH - Segment focus
  • 102: Thermo Fisher Scientific Inc. - Overview
  • 103: Thermo Fisher Scientific Inc. - Business segments
  • 104: Thermo Fisher Scientific Inc. - Key offerings
  • 105: Thermo Fisher Scientific Inc. - Key customers
  • 106: Thermo Fisher Scientific Inc. - Segment focus
  • 107: Currency conversion rates for US$
  • 108: Research Methodology
  • 109: Validation techniques employed for market sizing
  • 110: Information sources
  • 111: List of abbreviations